Patients with Parkinson disease can suffer complications in the hospital if the individualized, highly structured care plans that manage their disease are not followed. Neurosurgeon Hooman Azmi, MD, FAANS, the coauthor (along with Fiona Gupta, MD) of "Parkinson's Disease for the Hospitalist: Managing the Complex Care of a Vulnerable Population," discussed what it takes to improve patient care for this population.
Patients with Parkinson disease can suffer complications in the hospital if the individualized, highly structured care plans that manage their disease are not followed. Neurosurgeon Hooman Azmi, MD, FAANS, the coauthor (along with Fiona Gupta, MD) of "Parkinson's Disease for the Hospitalist: Managing the Complex Care of a Vulnerable Population," discussed what it takes to improve patient care for this population. He is the director of the
Director of the Division of Functional and Restorative Neurosurgery at Hackensack Meridian Health University Medical Center.
You may need to log in to the website to access this podcast:
Listen above or through one of these podcast services:
The National Parkinson's Foundation's Aware in Care kit
Resource mentioned during the podcast:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Certain Patient Groups Continue to Be Underrepresented in PD Studies in the Netherlands
February 4th 2023With greater attention being paid to the heterogenous patient population, researchers questioned whether this has resulted in a more diverse group of patients included in Parkinson disease (PD) studies in the Netherlands.
Read More